SL
Sarah Luppino
Investor at M Ventures
Barcelona, Catalonia
Overview
Sarah Luppino is an Investor at M Ventures, specializing in technology investments with a focus on sustainability, frontier tech, and semiconductors. With a background in chemistry and a Doctor of Philosophy from Massachusetts Institute of Technology, she has successfully invested in companies like Concerto Biosciences (Series A) and holds board positions at various organizations, showcasing her expertise in venture capital and strategic decision-making.
Work Experience
Principal, Technology Investments
2021 - Current
Investment focus: Semiconductors, Sustainability & Frontier Technology
Board Director
2024
Board Director
2023
Board Director
2022
Concerto Biosciences reinvents humanity's relationship with microbes.
Raised $26,006,949.00 from Springboard Enterprises.
Board Director
2022
Altoida is creating a new gold standard in brain health with Precision Neurology.
Raised $24,749,815.00 from M Ventures, VI Partners, Alpana Ventures, b2venture, Whitecap Venture Partners, FYRFLY Venture Partners, Hikma Ventures and HonorHealth.
Board Observer
2022
Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.
Raised $22,756,543.00 from Pace Ventures, TRAC, Metaplanet, Ultratech Capital Partners and TRAC.
Member
2021
Strategy Consultant
2018 - 2020
Energy & Sustainability Analyst
2017 - 2018
PhD Candidate
2012 - 2017